SCHEMBL19701974

SCHEMBL19701974

CC(=O)N1CCN(c2cccc(C(C)C)c2)C2(CC2)C1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.48
NOTUM Q6P988 2/20 0.43
ADAM10 O14672 1/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 4/20 0.39
ALDH1A1 P00352 3/20 0.39
CYP1A2 P05177 3/20 0.39
USP2 O75604 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPK1 P28482 2/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 1/20 0.39
ESR1 P03372 1/20 0.39
HIF1A Q16665 1/20 0.38
CYP2C9 P11712 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PANK3 Q9H999 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19701949 0.86 PIK3CD (0.47) PIK3CDNOTUMADAM10CYP3A4CYP2D6
SCHEMBL19710837 0.83 PIK3CD (0.44) PIK3CDNOTUMCYP3A4CYP2D6ALDH1A1
SCHEMBL19701977 0.77 NOTUM (0.56) NOTUMADAM10CYP2D6ALDH1A1CYP1A2
SCHEMBL19701975 0.74 PIK3CD (0.43) PIK3CDNOTUMADAM10ALDH1A1HPGD
SCHEMBL19701972 0.73 NOTUM (0.41) PIK3CDNOTUMADAM10HPGDMAPK1
SCHEMBL19701971 0.73 PIK3CD (0.42) PIK3CDNOTUMADAM10CYP3A4CYP2D6
SCHEMBL19701999 0.72 DRD2 (0.47) PIK3CDNOTUMCYP3A4CYP2D6ALDH1A1
SCHEMBL19701955 0.71 NOTUM (0.52) PIK3CDNOTUMALDH1A1HPGDMAPK1
SCHEMBL19690191 0.70 PIK3CD (0.47) PIK3CDCYP3A4CYP2D6ALDH1A1CYP1A2
SCHEMBL31011275 0.70 ALDH1A1 (0.59) NOTUMALDH1A1HSD17B10KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2017-12-14 US disclosed
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS PIK3R3, JAK2, JAK3 PIK3CD 14/4885NOTUM 3221/4885ADAM10 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.